Administering

Self-administration of medicines

25 January 2023Self-administering medicines in all care settings and at home can benefit both individuals and organisations; it should be encouraged where safely achievable

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Responsibilities for the self-administration of medicines

25 January 2023Duties and responsibilities are outlined for both staff and individuals during the process of self-administration of medicines (SAM)

Preventing parenteral nutrition rapid over-infusion in babies

28 October 2022There is a risk of severe harm or death if PN is unintentionally infused too rapidly in babies. Healthcare professionals need to ensure safe practice.

Patient Group Directions (PGDs) and abortifacients

14 September 2020This article advises on the legal position on the supply/administration of abortifacients under PGDs.

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Directions (PGDs) in End of Life Care.

Offender healthcare settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in offender healthcare settings

Off-label or unlicensed product use under HMR 2012 exemptions

8 January 2020A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Off label medicine use under a Patient Group Direction

10 June 2021This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label').

Non-acute settings with healthcare input and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

SPS - Specialist Pharmacy Service

NHS